Skip to content

Tomoyuki Miyazaki

2 papers in the library · 13 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

Association between Intravenous Ketamine Treatment and Cognitive Function in Patients with Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Trial

Pharmacopsychiatry July 7, 2026 Kie Nomoto, Yohei Ohtani, Taisuke Yatomi et al.

Introduction: While the rapid and robust effects of ketamine on depressive symptoms in treatment-resistant depression (TRD) have been demonstrated, the influence of ketamine treatment on cognitive function has not yet been fully elucidated. We aimed to evaluate the effects of ketamine treatment on cognitive function as part of a study that investigated the efficacy of repeated ketamine...

Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial.

Psychiatry and Clinical Neurosciences December 1, 2024 Yohei Ohtani, Hideaki Tani, Kie Nomoto-Takahashi et al. 13 citations

Although the antidepressant effect of ketamine on treatment-resistant depression (TRD) has been frequently reported in North American and European countries, evidence is scarce among the Asian population. We aimed to evaluate the efficacy and safety of intravenous ketamine in Japanese patients with TRD. In this double-blind randomized placebo-controlled trial, 34 Japanese patients with TRD were...